Institutional investors purchased a net $1.2 million shares of ZIOP during the quarter ended December 2015 and now own 39.64% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MIZUHO SECURITIES USA, INC. Bought 47.7 Thousand shares of ZIOPHARM Oncology Inc